Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy (TEMPO II)
Sponsor: Morten Steen Kvistholm Jensen
Listed as NCT05569382, this PHASE4 trial focuses on Non-obstructive Hypertrophic Cardiomyopathy and remains actively recruiting participants. Sponsored by Morten Steen Kvistholm Jensen, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Apr 2025 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
Nov 2022 — Jan 2023 [monthly]
Recruiting PHASE4
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Morten Steen Kvistholm Jensen
- Odense University Hospital
- Viborg Regional Hospital
- Zealand University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .